Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farlong Pharmaceutical is a science-based nutraceutical company that specializes in the development and distribution of premium herbal supplements and traditional Chinese medicine (TCM). Founded in 1998 and headquartered in California, the company was acquired by the Beijing Tong Ren Tang Group in 2013, serving as its primary North American arm. Farlong focuses on integrating ancient herbal wisdom with modern pharmaceutical manufacturing standards to produce high-quality dietary supplements. Their core product offerings include proprietary ingredients such as Lifeflower (Erigeron breviscapus) and Nattokinase, which target cardiovascular and cognitive health. The company maintains its own GAP-certified cultivation bases and GMP-compliant manufacturing facilities to ensure vertical integration and product purity. Farlong's mission is to provide natural, evidence-based health solutions to a global consumer base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Ton Ren Tang Farlong.